AMENDMENT – NUMBER ONE AGREEMENTEmployment Agreement • November 9th, 2009 • Antigenics Inc /De/ • Biological products, (no disgnostic substances) • Massachusetts
Contract Type FiledNovember 9th, 2009 Company Industry JurisdictionThis Amendment Number One (this “Amendment 1”) is effective as of July 2, 2009 by and between Antigenics Inc., a Delaware corporation, having its principle place of business at 3 Forbes Road, Lexington, Massachusetts 02421, USA (the “Company”) and Karen Valentine (the “Executive”). Capitalized terms not otherwise defined herein shall have the meaning set forth in the Agreement (defined below).
AMENDMENT – NUMBER ONE AGREEMENTEmployment Agreement • November 9th, 2009 • Antigenics Inc /De/ • Biological products, (no disgnostic substances) • Massachusetts
Contract Type FiledNovember 9th, 2009 Company Industry JurisdictionThis Amendment Number One (this “Amendment 1”) is effective as of July 2, 2009 by and between Antigenics Inc., a Delaware corporation, having its principle place of business at 3 Forbes Road, Lexington, Massachusetts 02421, USA (the “Company”) and Kerry Wentworth (the “Executive”). Capitalized terms not otherwise defined herein shall have the meaning set forth in the Agreement (defined below).
AMENDMENT – NUMBER ONE AGREEMENTEmployment Agreement • November 9th, 2009 • Antigenics Inc /De/ • Biological products, (no disgnostic substances) • New York
Contract Type FiledNovember 9th, 2009 Company Industry JurisdictionThis Amendment Number One (this “Amendment 1”) is effective as of July 2, 2009 by and between Antigenics Inc., a Delaware corporation, having its principle place of business at 3 Forbes Road, Lexington, Massachusetts 02421, USA (the “Company”) and Shalini Sharp (the “Executive”). Capitalized terms not otherwise defined herein shall have the meaning set forth in the Agreement (defined below).